当前位置: 首页 > 期刊 > 《新医学》 > 2021年第7期
编号:650096
单中心卵巢畸胎瘤患者中合并抗N-甲基-D-天冬氨酸受体脑炎的比例调查及临床特征分析
http://www.100md.com 2021年10月14日 新医学 2021年第7期
     蒋慧云?黄珊瑜?李小毛

    【摘要】目的 探究卵巢畸胎瘤患者中發生抗N-甲基-D-天冬氨酸受体(NMDAR)脑炎的比例,并将合并抗NMDAR脑炎的卵巢畸胎瘤患者与未合并抗NMDAR脑炎的卵巢畸胎瘤患者的临床特征进行总结对比。方法 收集卵巢畸胎瘤患者的临床资料,将其分为合并抗NMDAR脑炎组与未合并抗NMDAR脑炎组,对其临床特征进行对比分析。结果 共收集到168例卵巢畸胎瘤患者,其中14例(8.3%)合并抗NMDAR脑炎;合并抗NMDAR脑炎的卵巢畸胎瘤患者年龄低于未合并抗NMDAR脑炎的卵巢畸胎瘤患者[(23.8±5.5)岁 vs. (29.8±9.1)岁,P = 0.016]。合并抗NMDAR脑炎的卵巢畸胎瘤患者肿瘤标志物以癌抗原125及血清铁蛋白升高为主,而未合并抗NMDAR脑炎的卵巢畸胎瘤患者肿瘤标志物以糖类抗原199升高为主。合并抗NMDAR脑炎与未合并抗NMDAR脑炎的卵巢畸胎瘤患者的肿瘤组织均可含有神经组织。结论 卵巢畸胎瘤患者中发生抗NDMAR脑炎的比例不低,对于无明显症状的卵巢畸胎瘤患者,可考虑积极行手术治疗,以降低发生抗NMDAR脑炎的风险。

    【关键词】卵巢畸胎瘤;抗N-甲基-D-天冬氨酸受体脑炎;神经系统副肿瘤综合征;癌抗原125;血清铁蛋白;糖类抗原199

    Proportion and clinical features of anti-N-methyl-D-aspartate receptor encephalitis in patients with ovarian teratoma in a single center Jiang Huiyun, Huang Shanyu, Li Xiaomao. Department of Gynecology, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China Corresponding author, Li Xiaomao, E-mail: lixmao@ mail. sysu. edu. cn

    【Abstract】Objective To determine the incidence of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in patients with ovarian teratoma and to compare the clinical characteristics between ovarian teratoma patients with and without anti-NMDAR encephalitis. Methods Clinical data of ovarian teratoma patients were collected and divided into the anti-NMDAR encephalitis group and non-anti-NMDAR encephalitis group. Clinical characteristics were statistically compared between two groups. Results Among 168 patients with ovarian teratoma ......

您现在查看是摘要页,全文长 13050 字符